Q3

INDOCO REMEDIES LTD.

INDOCOFY2521 Jan 2025

Revenue-5.1%

Net Profit-183.7%

OPM-18.67%

P&L

Quarterly Consolidated

Revenue

-5.1%410.55

Expenditure

+1.0%443.35

Net Profit

-183.7%-28.40

NPM -6.90%-198.7%EPS ₹-3.08-182.6%

vs Q2 FY25

Informational and educational content only. Not investment advice.